A mechanism of antioxidant activity of calcium antagonist verapamil against LDL oxidation.
Karmansky
I
I
Department of Biochemistry, Carmel Hospital, Haifa, Israel. biochem@actcom.co.il
Gruener
N
N
D000328:Adult; D000578:Amidines / Q000378:metabolism; D000975:Antioxidants / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D003300:Copper / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008297:Male; D010084:Oxidation-Reduction; D013054:Spectrophotometry, Atomic; D014700:Verapamil / Q000494:pharmacology*
D000578:Amidines; D000975:Antioxidants; D002121:Calcium Channel Blockers; D008077:Lipoproteins, LDL; C046728:2,2'-azobis(2-amidinopropane); D003300:Copper; D014700:Verapamil